Lmr Partners LLP Annexon, Inc. Transaction History

Lmr Partners LLP

$10.2 Billion
Q2 2024

A detailed history of Lmr Partners LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 219,600 shares of ANNX stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

219,600

Holding current value

$1.54 Million

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $94,218 - $187,932	25,192 New	25,192 $96,000
Q2 2022 Aug 15, 2022	BUY	$2.11 - $4.06 $23,465 - $45,151	11,121 New	11,121 $42,000

Others Institutions Holding ANNX

# of Institutions

156

Shares Held

101M

Call Options Held

3.73M

Put Options Held

1.3M

Bain Capital Life Sciences Investors, LLC Boston, MA

8.45M
Shares

$59.4 Million
8.47% of portfolio
Satter Management Co., L.P.

7.41M
Shares

$52.1 Million
71.21% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$49.2 Million
1.05% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$46.3 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.43M
Shares

$45.2 Million
2.05% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account